Introduction
============

As an alternative to mastectomy for breast cancer, approaches that permitted breast conservation began in France in the thirties and from the very beginning, included radiation therapy (Baclesse et al., [@B3]). Nearly half a century later, breast conservation surgery with radiotherapy proved to achieve the same outcome as mastectomy, for both local control and survival (Fisher et al., [@B11]; Veronesi et al., [@B34]).

During this phase, the radiation technique used identified the breast as the target based on clinical references and anatomical boundaries which were used to reproduce a daily setup. Initially this setup was only clinical, but in the sixties radiation simulator machines were introduced, enabling a more accurate daily positioning based on fluoroscopic and radiological references to bony landmarks obtained before initiation of treatment, in a preparation session defined as simulation. At simulation, reference images are generated, to be compared to the verification images obtained directly from the treatment machine, documenting the beam's eye view, every few radiotherapy sessions. If differences are found the necessary adjustments are introduced. The advent of radiotherapy planning based on CT imaging in the eighties (Jelden et al., [@B22]) allowed the possibility of obtaining body contours as well as anatomical visualization of thoracic organs, thus revolutionizing the accuracy of treatment planning. In 1991, three-dimensional treatment planning for breast cancer was introduced (Solin et al., [@B32]) and established as routine almost a decade later.

From the beginning it was noted that patients with large breast size experience increased acute and late skin toxicities, particularly at the infra-mammary fold. While the option of breast conservation therapy (BCT) was also offered to them, cosmetic results were found to be inferior (Gray et al., [@B20]) and for this reason some cautioned against the use of radiotherapy in this group (Bentel et al., [@B5]). Late effects of increased fibrosis, retraction, and telengiectasias were frequently noted. This was likely attributed to the increased separation distance of the target volume and frequent dose inhomogeneity due to the shape of the breast tissue that often will flop over laterally, when supine.

A Prone Setup for Women with Large Breast Size
==============================================

Several techniques have been explored to correct for these technical limitations in an attempt to assure a good cosmetic outcome for women with large breast size who necessitate radiation therapy.

Attempts to improve the homogeneity of dose distribution included: (a) changing/mixing beam energies (Monson et al., [@B29]), (b) introducing immobilization devices that displace the breast from the chest wall (Zierhut et al., [@B36]), and (c) modifying patient positioning, for instance with the lateral decubitus (LD) position (Baclesse et al., [@B3]; Cross et al., [@B8]). Approaches which included the construction of a thermoplastic mold or utilized a reinforced PVC ring and Styrofoam™ (Bentel and Marks, [@B4]; Zierhut et al., [@B36]) to pull the lateral breast tissue anteriorly and upright when supine and to decrease the separation of the tangents, as well as reducing the contact of the breast tissue with the chest wall at the infra-mammary fold were proposed. These devices failed to gain wide acceptance and standard application likely due to decreased reproducibility and patient discomfort.

Since the inception of this area of research, investigators have explored the potentially beneficial dosimetric effects of treating patients in the LD position. The LD position was introduced by Baclesse in the 1950s and has been applied to thousands of breast cancer patients treated at the Institute Curie and at other radiotherapy centers in France (Fourquet et al., [@B17]). The greatest advantage of the LD technique is in decreasing the separation by reducing breast thickness, thus decreasing inhomogeneity and the need for beam modifiers. The greatest challenge is the difficulty in reproducing the daily setup as well as in obtaining an accurate contour for calculation of dose distribution before CT simulation was available to verify this setup. The technique was originally designed to treat patients with a fixed gantry but it was maintained after the introduction of rotating gantries to treat women with larger breasts, instead of treating them in supine position.

The MSKCC Experience of Prone Radiotherapy
==========================================

In 1994, investigators from Memorial Sloan-Kettering Cancer Center (MSKCC) reported prone breast radiotherapy as a viable alternative to the classic supine positioning for patients with large medial to lateral separation (Merchant and Mccormick, [@B27]). A platform for prone breast radiotherapy was developed to add to the treatment couch that was made commercially available (Victoreen®, Model 37-018; Figure [1](#F1){ref-type="fig"}). The platform has a modifiable aperture (by sliding an insert in the lateral direction) through which the index breast hangs away from the thorax by gravity when the patient is prone. The ipsilateral arm is placed either at the side or above the head. A wedge under the contralateral side achieves an axial rotation of the patient toward the treated breast. The medial and lateral borders of the breast tissue are clinically assessed and define the field for two tangential, parallel opposed photon beams.

![**Prone breast positioning table Victoreen® Model 37-018**. The table was designed based on MSKCC experience.](fonc-01-00031-g001){#F1}

In an initial report, representative isodose distributions were generated for a patient simulated in both prone and supine positions. The isodose distribution was done in the transverse plane for both techniques and optimized with the use of beam wedges. More homogeneous isodose distributions were found for the patients in the prone position. The technique, as initially proposed by the MSKCC group, did not require CT simulation (Merchant and Mccormick, [@B27]). In a subsequent report of 245 patients treated from 1992 to 2004, tolerability and efficacy of this approach were confirmed (Grann et al., [@B19]; Stegman et al., [@B33]). More recently, the same group reported a dosimetric analysis of 20 patients planned with a simplified intensity modulated radiation therapy (IMRT) to treat the breast in prone position. Dose homogeneity was improved, particularly in women with larger, pendulous breasts (Goodman et al., [@B18]).

In addition, in 2009 a retrospective analysis of the outcome of 128 patients treated in the prone position, who had received the accelerated Canadian fractionation regimen (42.4 Gy in 16 fractions of 2.65 Gy) modified to include a sequential 10 Gy boost delivered in 2 Gy fractions was reported. At a median follow-up of 18 months, comparable early tumor control and cosmesis to those achieved by standard fractionation were demonstrated (Croog et al., [@B7]).

The USC Experience of Prone Breast Radiation Therapy
====================================================

In the early 1990s, we started exploring accelerated partial breast radiation in the prone position through a series of studies conducted at the University of Southern California (Luxton et al., [@B25]; Formenti et al., [@B15]). A radiosurgery-like technique was investigated, based on the use of multiple non-coplanar beams. The patient was positioned with arms kept adjacent to the chest on a home-built wooden platform (Figure [2](#F2){ref-type="fig"}). The platform had a system of removable concentrical inserts at the level of the breast. Each insert consisted of several concentrical ring components to accommodate different size breasts. With the contralateral insert in place to close the opening, the target breast was centered in the ipsilateral opening, adjusted to the specific breast size by using the appropriate ring inserts. The distal part of the board extended from the end of the treatment couch, enabling full couch rotation to use superior--oblique and superior--inferior beams. To prevent metal distortions at planning CT, the board did not contain metal parts: the thickness of the board was chosen to prevent flexibility under the patient's weight. This approach was designed for partial breast treatments only. It was incompatible with inclusion of the whole breast tissue by tangential fields since part of the breast tissue was superior to the opening of the platform: with the entire breast volume as target the tangential fields would have encountered the ipsilateral arm (kept adjacent to the chest) and the side bar (approximately two inches of wood). A beam eye view from below the platform easily demonstrated inclusion of only part of the breast tissue, a few cm distal from the bony reference of the rib cage.

![**USC prone breast board for partial breast treatment**. The contralateral opening is covered by the solid disk, the indexed breast is hanging through one of the rings inserted into the ipsilateral opening.](fonc-01-00031-g002){#F2}

This first platform (Figure [2](#F2){ref-type="fig"}) was used in a pilot--feasibility trial of ten consecutive patients who were assigned a five fractions regimens. Nine were treated with the proposed technique, with planning target volume (PTV) defined on the basis of CT findings at the visualized tumor cavity plus a 1--2-cm margin. A 4 mV x-ray beam was used to deliver the prescribed dose through multiple fixed fields that consistently avoided exiting in the lung or heart, utilizing multiple couch rotations. All patients received five fractions over 10 days (total dose range, 25--30 Gy): three were randomly assigned to receive 5.0 Gy per fraction; four, 5.5 Gy; and two, 6.0 Gy, respectively. Cosmesis was assessed by patients and physicians before treatment and at least 36 months after treatment. At this minimum follow-up (range, 36--53 months) all patients were alive and disease-free with good to excellent cosmesis (Formenti et al., [@B15]). This experience established feasibility of prone PBI and justified further investigation of this approach.

The NYU Experience: Prone Breast Radiation Devices
==================================================

Research in prone breast irradiation continued at New York University with focus on designing a device compatible with prone "whole breast" radiotherapy. It became clear that in order to assure interfraction reproducibility, a very precise immobilization technique needed to be in place at the time of CT simulation to assure exact replication on the treatment table. Moreover, a CT simulator with a larger bore became necessary for imaging the patient on the prone table. A new breast board was built, eliminating the side bar characteristic of the USC design. In addition, the patient setup was changed to an "arms-up" position (Figure [3](#F3){ref-type="fig"}, version 1). Again, no metal was included in the board to prevent image distortion at CT planning. Since it was found that utilizing small tangential fields resulted in acceptable dose distribution, the requirement for full couch rotation became unnecessary, and permitted modification of the design of the table to accommodate a more comfortable position (Figure [3](#F3){ref-type="fig"}, version 2), which greatly increased patients' comfort. Made of solid wood, this version of the prone board was non-deformable with weight and relatively heavy, requiring two therapists to position it on the couch.

![**(A)** NYU design, version 1. The board extends over the treatment couch, allowing couch rotation. By eliminating the ipsilateral bars tangential fields are possible. **(B)** NYU design, version 2. The board fully rests on the treatment couch. The leg support allowed a thinner board; therefore a soft cushion could be placed on the top, for patient comfort. Couch rotation is limited (\<10°). **(C)** NYU design, version 3. Two-inch thick memory foam layer on top of 5 inch Styrofoam™, wrapped in washable vinyl cover. (For large breast carriers, additional Styrofoam™ layers can be used under the mattress).](fonc-01-00031-g003){#F3}

An additional step to ease transport of the board while at the same time enhancing the comfort of the prone patient was the introduction of the prone mattress, i.e., a modular breast board made of a thick memory foam layer placed on top of 12.5 cm Styrofoam™ (Figure [3](#F3){ref-type="fig"}, version 3). The memory foam assures consistently reproducing the same degree of compression with weight, making the position reproducible for each patient over multiple radiation therapy sessions. Importantly, the prone mattress is light and easily removed from the couch. Its simple design has made it affordable and easy to build at multiple international radiation oncology centers. Limitations are the absence of a holding bar to maintain the arms and hands in the same position, and the fact that it was not designed to be specifically indexed to the couch, thus requiring therapists experienced in prone breast radiation and the accurate use of positioning lasers to prevent differences in a day-to-day setup (Device for prone breast radiotherapy. US Patent No. 7.763.864 B2).

The experience acquired in the design of each generation of devices was later shared in collaborations with industry. We provided un-remunerated feedback to the design of the commercial prone breast positioning devices of Orbital Therapy Inc. (ClearVue™) and Varian Medical Systems Inc. (Access360™). The ClearVue™ model (Figure [4](#F4){ref-type="fig"}A,B) is a table-top design with good access and visibility for accurate setup. The soft cushion is ergonomically designed for greater patient comfort. It is built of carbon fiber, making it lightweight and causing very low radiation absorption. The Access360™ model from Varian (Figure [5](#F5){ref-type="fig"}) currently undergoing evaluation is essentially an extension of the treatment couch. Built of carbon fiber, it has an additional opening of the soft cushioning lining to visualize the field more cranially if the supraclavicular region is a target. Although couch rotation is possible, large-angle superior--oblique fields are not feasible, as they would encounter the arms of the patient.

![**(A)** ClearVue™ System (Orbital Therapy): carbon fiber plate and board, soft cover for patient comfort. **(B)** The central segment can be rotated for right breast patients.](fonc-01-00031-g004){#F4}

![**Access360™ (Varian Medical Systems): Built of carbon fiber mesh, with soft cushion on top**. Attaches to the end of the treatment couch (replaces the upper section). An uncovered section of the mesh enables supraclavicular fields.](fonc-01-00031-g005){#F5}

While better engineered devices have permitted better indexing of the table and more comfortable and reproducible positioning, the basic dosimetric advantages of a prone setup became apparent since the beginning, reflecting the more advantageous access to the target when gravity distances the breast parenchyma from the chest wall.

Results of NYU Prone Breast Radiation Therapy Trials
====================================================

While many breast cancer patients requiring whole breast radiation therapy have been treated in the prone position with standard fractionation regimens, NYU conducted a series of clinical trials to test hypo-fractionated, accelerated regimens of breast radiotherapy.

The first NYU trial of prone radiation tested partial breast accelerated fractionation (PBI) as part of a DOD IDEA Grant "Hypo-Fractionated Conformal Radiation Therapy to the Tumor Bed after Segmental Mastectomy" awarded in 2000. Clinical and dose-volume histogram results of the first 47 patients accrued to this protocol were reported in 2004 (Formenti et al., [@B16]) and the 5-year results were recently presented at ASTRO (Formenti, [@B12]). All patients were treated prone with three-dimensional conformal radiotherapy after breast conserving surgery. Eligibility criteria were postmenopausal women with Stage T1N0 breast cancer that had initially refused to undergo 6 weeks of standard radiotherapy and were interested in a shorter regimen. The postoperative cavity was defined as the clinical target volume with a 1.5-cm margin added to determine the PTV. The prescription dose was 30 Gy at 6 Gy/fraction in five fractions on Monday, Wednesday, Friday, Monday, and Wednesday.

The encouraging experience with prone PBI provided the foundations to test prone radiotherapy targeting the whole index breast. In 2002, NYU started a Phase I--II trial of prone accelerated intensity modulated radiation therapy to the whole breast that included a concomitant boost to the tumor bed (Dewyngaert et al., [@B10]). This approach was chosen to open the access to hypo-fractionation to patients with more aggressive tumors with potentially higher risk of local recurrence. Eligible patients for this IRB-approved prospective trial were stage I or II who had undergone breast conserving surgery with negative margins. A dose of 40.5 Gy, delivered at 2.7 Gy in 15 fractions, was prescribed to the index breast with an additional concomitant boost of 0.5 Gy delivered to the tumor bed, for a total dose of 48 Gy to the lumpectomy site. Dosimetric results of the trial were reported in 2007 after 91 patients had been treated, with a median follow-up of 12 months (Formenti et al., [@B13]). The technique was feasible in all patients regardless of breast volume. Sparing of the heart was achieved as prescribed by the protocol, that required limiting 5% of the heart volume to receive ≥18 Gy and ≤10% of the ipsilateral lung volume to receive ≥20 Gy.

Reproducibility of the NYU Prone Technique
==========================================

The advantages of a prone setup have long been recognized in diagnostic radiology where both breast biopsies and breast MRI are routinely performed in the prone position since it minimizes the motility of the anterior chest wall, reducing movement artifact (Wolfman et al., [@B35]).

Over the years, we have developed a reliable system to reproduce for treatment the position imaged at simulation. At the time of simulation with the patient lying in the supine position, the superior, inferior, and mid-axillary borders were marked with fiducials and the patient's midline is defined by the placement of a radio--opaque wire over the sternum. Afterward, the patient is positioned prone with the breast situated approximately in the center of the opening of the breast board. The plane passing through the nipple is defined by laser lights and it is used as a reference plane to establish triangulation tattoos for leveling the patient on a daily basis. Three tattoos define this plane: two lateral leveling tattoos at mid-level of the torso in the anterior--posterior dimension and a posterior tattoo, on the back of the patient, off-midline in the direction of the breast side that is being treated. The latter provides the therapist with a final check to confirm, once prone, whether the right or left breast is treated (Figure [6](#F6){ref-type="fig"}A,B). An additional tattoo is placed on the skin of the treated breast to locate the isocenter prior to each treatment. The breast tattoo indicates the superior--inferior and anterior--posterior level of the isocenter. In this way, the isocenter is defined simply by moving along a horizontal line passing through the breast tattoo. The depth of the isocenter is chosen close to midline, maintaining a minimum depth of 1.5 cm in tissue on the medial aspect of the breast. Applying this method of spatial reference, NYU has reported the interfraction and intrafraction setup variability for prone breast radiation therapy in a series of consecutive patients enrolled in the concomitant boost protocol (Mitchell et al., [@B28]). An electronic portal device with cine capability acquired images on 10 consecutive patients: inter- and intra-fraction variability of the fiducial markers were demonstrated to range from 0.02 to 0.14 cm. The findings resulted in a CTV to PTV expansion of 1.4 cm, confirming the adequacy of our current protocol of 1.5 cm expansion.

![**(A,B)** Placement of the localization and setup BBs.](fonc-01-00031-g006){#F6}

In another study, the role of cone beam computerized tomography (CBCT) imaging to assure accurate/reproducible partial breast setup was analyzed in 343 CBCT, from 70 consecutive patients (Jozsef et al., [@B23]). The patient was positioned utilizing lasers and markers/tattoos, then portal images were taken, but no adjustment implemented. This was followed by CBCT and the suggested shifts were applied. A second set of portal images then verified the corrected setup. If the images did not accurately reproduce the digital radiograph generated after simulation, the patient was re-positioned and the procedure was repeated. The analysis of the shifts detected led to the following results:

1.  In 7/343 cases (2%) was a repeated setup necessary.

2.  The average shifts over five fractions never exceeded 1.3 cm (in any direction and in any patients).

3.  The average magnitude of shifts (sum of squares of the shifts in the three principal directions) was 0.68 cm.

4.  In three patients (4.3%) was a shift exceeding 1.5 cm in any direction detected more than once during the course.

We concluded that the setup is reasonably accurate and reproducible, and that a 1.5-cm margin is sufficient. This margin size was dosimetrically verified by modeling the summed dose distribution over five fractions for the first 21 patients. Specifically, 95% of the CTV (surgical cavity plus 2--3 mm) was covered by the prescription dose in all but one case (20/21, 95.2%). Furthermore, 95% of the prescription dose covered 95% of the PTV--Eval (CTV plus 1.5 cm margin, excluding possible overlapping lung and 0.7 cm thick superficial layer from the skin) in 19/21 patients (90.5%; Jozsef et al., [@B23]).

Other groups have compared prone versus supine treatment utilizing 4D-CT, demonstrating decreased intrafraction variation from respiration. Morrow et al. ([@B30]) demonstrated that respiratory motion of the chest wall was drastically reduced from 2.3 ± 0.9 mm in supine position to −0.1 ± 0.4 mm in prone position utilizing 4D-CT in three patients. Kirby et al. ([@B24]) had similar results in 25 patients. In contrast to our experience, both groups found greater systematic and random setup errors with the prone technique as compared to supine treatment. Neither group, however, utilized additional fiducial marks as we do to better reproduce the daily setup.

Heart Exposure When Prone
=========================

A concern raised regarding prone breast irradiation is the displacement of the heart anteriorly when prone. Increased mortality from heart disease 10--15 years after receiving irradiation to the left breast compared to patients irradiated to the right breast demonstrated the late cardiovascular morbidity associated with inclusion of the organ in the radiation field. Consistently, the volume of heart in the field correlates with perfusion deficits and microvascular disease and inclusion in the field of the left anterior descending artery contributes to atherosclerosis and coronary artery disease (Darby et al., [@B9]).

Investigators at Duke University retrospectively compared simulation CT scans of 16 patients treated in the supine position with breast MRI's obtained in the prone position (Chino and Marks, [@B6]). The mean displacement of the heart was 19 mm anteriorly to study whether the prone setup would better spare the heart. Concerns about this work have been discussed (Lymberis and Formenti, [@B26]).

However, we also occasionally noticed a similar positional shift of the heart early in the beginning of the NYU experience with prone breast irradiation, attributable to a "sinking" of the left chest wall and breast tissue below the board with an axial rotation toward the opening of the board. Rarely in patients when the heart moves by gravity in the same direction does it reach the chest wall below the level of the prone board, and is encompassed by the tangent treatment fields. By turning the patient's head toward the treated breast we have corrected for this rotation and drastically limited this problem. With this correction, during the past 400 prone simulations for left breast cancer, none of the patients were found to have any volume of heart included in the tangent fields.

To better study this issue and that of possible anatomic variance among patients, we designed NYU Trial 05-181 in which 400 patients, 200 with left and 200 with right breast cancer, consented to undergo two CT simulations for planning both prone and supine (Formenti et al., [@B14]).

The results of this trial demonstrated that in 15% of patients with left breast target lesions, the supine position decreased the amount of heart in the field by a mean of 6 cc. Eighty-five percent of the patients with left breast target lesions benefited by the prone treatment, decreasing the amount of heart in the field by a mean of 11 cc. Sixty-nine percent of the left-sided breast patients with an A/B cup (\<750 cc breast volume) benefited from treatment in the prone position, as did 96% with a C cup (750--1500 cc) and 99% with a D cup (\>1500 cc). These results have modified our standard practice of breast radiation therapy: we now simulate all patients in prone position and treat prone unless part of the heart is included in the tangent field. In the latter case, the patients are re-simulated supine.

Common Challenges of a Prone Setup
==================================

By having treated several thousands of women over the past 15 years, we have accumulated an extensive experience on how to optimally set up a patient in the prone position, and have identified many of the challenges with this setup. Twice a year, NYU offers a 2-days Continuous Medical Education course, to share our experience in prone breast radiotherapy. Through the interaction with the participants of these sessions, we have identified several common areas of confusion or error. These include: (1) inadequate coverage of the target, i.e., the entire parenchyma of the index breast; (2) incorrect positioning of the patient, particularly in women with large breast size; (3) allowing for excessive "sinking" and rotation of the patient toward the opening of the board.

Assuring whole breast coverage
------------------------------

The first and most important issue in whole breast prone radiotherapy, is the recognition of the boundaries of the index breast when prone. At the time of simulation radio--opaque be-bees are paced on the reference plane, to define the superior, inferior, and medial edges of the target. Specifically, the superior edge of the field is defined at the inferior margin of the clavicular head. The inferior margin is placed at 2 cm below infra-mammary fold, and the medial margin on the midline of the patient, anterior to the sternum. The posterior edge is defined by CT imaging through a virtual line that connects on the reference transverse plane the midline, sternal marker to a point on the skin of the lateral chest wall which is just anterior to the edge of the latissimus dorsi muscle, to assures inclusion of the breast parenchyma. While the superior, medial, and inferior margins can be easily maintained consistent with those of a supine setup the lateral and deep margins are often a source of confusion.

Part of the confusion reflects the fact that, when prone the pectoralis major may also move away from the chest wall by gravity: since the breast tissue is external to the muscle, the virtual line that defines the deeper edge of the tangent fields, lies almost always external to the ribcage.

Preventing incorrect positioning
--------------------------------

A frequently observed mistake consists of inadequate alignment of the patient on the table at the time of prone CT simulation. Figure [7](#F7){ref-type="fig"} demonstrates a typical case: in panel G1 the patient is initially set up with the sternum lateral to the edge of the mattress. In this case, the contralateral breast creates a wedge at the midline. To avoid inclusion in the field of the contralateral breast the angle of the tangents would include part of the heart and LAD. This patient required re-simulation: once correctly aligned with the sternum more medial toward the edge of the mattress and the contralateral breast better displaced, the tangents avoided the contralateral breast and the heart and LAD, while including the entire parenchyma of the index breast (lateral edge is just anterior to the latissimus dorsi).

![**(A)** Initial set up with the sternum lateral to the edge of the mattress and the contralateral breast creating a wedge at the midline. To avoid the contralateral breast the angle of the tangents would include part of the heart and LAD. **(B)** Once correctly aligned with the sternum more medial toward the edge of the mattress and the contralateral breast better displaced, the angle of the tangents permits exclusion of the contralateral breast, heart, and LAD, while including the entire parenchyma of the index breast (lateral edge is just anterior to the latissimus dorsi).](fonc-01-00031-g007){#F7}

Preventing "sinking" and rotation of the patient toward the opening of the board
--------------------------------------------------------------------------------

As mentioned before, this issue was prevalent at the beginning of our experience. Two interventions corrected this problem. First, we try to position the sternum of the patient on the edge of the board, and assuring support of the board at the midline. Second, turning the patient's head laterally toward the treated breast, consistently prevents this effect. The rotation of the neck, physiologically reflects in an adjustment of the spine and the rest of the body that compensates for "sinking" and axial rotation toward the index breast. With these two precautions, during the past 463 prone simulations for left breast cancer, none of the patients were found to have any volume of heart included in the tangent fields.

Limitations of the Prone Technique and Current NYU Research
===========================================================

The experience with a prone setup for breast radiotherapy has identified some of the limitations of this approach and has inspired a series of ongoing trials to address new scientific questions.

As stated earlier, we routinely use a prone simulation for both trial and standard fractionation regimens. Neither breast size nor patient's weight have ever presented a problem. Exceptions include patients requiring four-fields radiation therapy to include the axillary nodes and patients in our trials of concurrent chemo-radiation for locally advanced breast cancer (Adams et al., [@B1]) and those rare patients who cannot tolerate the prone decubitus. A common complaint is pain from the tension on the neck and spine muscles, to maintain the position. Some of the commercially available prone boards include an head-holder similar to those used for body massage, that enables support with a straight neck. We reserve this approach to women with history of neck injury or disk problems.

Another identified limitation of the prone technique is a decrease in axillary nodal coverage (Alonso-Basanta et al., [@B2]). Dosimetry of the axilla (level I--III nodes) was assessed in twenty patients imaged and planned both supine and prone. Standard tangent fields were designed for the whole breast to deliver a prescribed dose of 50 Gy. Dose-volume histograms were compared between the two sets. For each patient, coverage of breast tissue and tumor bed was readily achieved by either technique. However, in either position; treatment of the nodal regions was inadequate, and, on average, the mean dose to levels I--III axillary nodes was approximately 50% less in the prone as compared to the supine position. A prone setup is generally inadequate in patients requiring radiotherapy to axillary nodes. However, a prone technique that targets the breast and level 3 and supraclavicular nodes is feasible (Sethi et al., [@B31]) and it is being tested in a prospective trial of breast cancer patients with \<5 involved axillary nodes, after an adequate axillary dissection.

Similarly, we have questioned the need of IMRT when treating prone (Hardee et al., [@B21]): we are currently conducting a prospective randomized study that tests the role of a weekly boost, instead of a daily concomitant boost. If proven equivalent, a weekly boost could enable prone breast without IMRT, making this approach more feasible and cost-effective.

Finally, the combination of concurrent carboplatin and accelerated adjuvant radiotherapy is explored in a trial open to triple negative tumor carriers and the role of imaged guided radiotherapy in studied as part of PBI.

Conclusion
==========

Over the years, our team has developed considerable experience in prone radiotherapy of the breast. In the interest of space, many details were omitted and this review focuses on the most relevant issues on this subject. Reproducibility of the daily setup is of tantamount importance in being able to exploit the advantage of immobilization of the chest wall and breast by reducing breathing motion when prone, and it is the very first step to assure the success of this approach. Importantly, a prone setup is advantageous to most women needing breast radiation therapy, independently from their breast size. When correctly positioned prone, it is possible to exclude the heart and drastically decrease the amount of lung in the field compared to supine, preventing late effects to the normal tissue. Moreover, the decreased acute toxicities of this approach, despite the inclusion of a concomitant boost to the tumor bed in accelerated, shorter radiotherapy regimens, have made it desirable to many patients.

However, prone accelerated breast radiotherapy with a concomitant boost remains a research approach. Its equivalence to a standard fractionation regimen is under investigation in RTOG 1005: the results of this prospective trial will decide if it can become a standard choice in breast radiotherapy.
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